The Taper Myth: Why “I’ll just stop” is the most expensive withdrawal plan you can make
There are two kinds of people when it comes to stopping a medication: the ones who assume withdrawal is a
General
The Supplement That Thinks It’s a Prescription: Top Interaction Myths That Get People in Trouble
Top supplement + prescription interaction misunderstandings There’s a particular kind of confidence that shows up in the pharmacy aisle: the
AI Became Your Patient’s Drug Counselor. Pharma Didn’t Get a Vote.
Somewhere between the formulary decision and the first filled prescription, a patient opens ChatGPT and asks: “Is Ozempic safe for
Pharma SEO Is Dead. AI Answers Killed It. Here’s What Replaces It.
A physician types “best GLP-1 for weight loss” into ChatGPT. A patient asks Claude which SGLT2 inhibitor has the fewest
Drug Information Accuracy Across ChatGPT, Gemini, Claude, and Perplexity: What Pharma Brand Teams Must Know Now
When a patient types ‘Can I take Ozempic if I have pancreatitis?’ into ChatGPT at 11 p.m., they are not
Which LLM Gives the Most Accurate Drug Information? A Pharma Brand Team’s Field Guide
A patient types ‘Can I take Ozempic and metformin together?’ into ChatGPT. A physician asks Gemini about semaglutide dosing for
The Pharma AI Monitoring Gap No One Owns Internally
Somewhere between medical affairs, pharmacovigilance, digital marketing, and IT, there is a gap large enough to swallow a drug brand.
When AI Gives Off-Label Drug Advice: What Pharma Must Track Now
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will
Detect AI Drug Misinformation Before It Hits Patients: A Pharma Playbook
At some point in the last eighteen months, the drug information environment crossed a threshold. Patients stopped asking Google first.
AI Monitoring for Medical Affairs: What to Track Before the FDA Does
When a patient asks ChatGPT whether they can take Ozempic while on metformin, that answer — accurate or not —
AI Doesn’t Read Drug Labels Like Humans Do — And Pharma Is Paying the Price
When a patient types “can I take Ozempic with metformin” into ChatGPT, they are not reading an FDA-approved label. They
Biosimilar AI Monitoring: The $100B Battle Playing Out in ChatGPT Right Now
Amgen’s Hadlima launched in the United States in July 2023. AbbVie’s Humira had dominated adalimumab prescribing for two decades. The
